EXPE
66
-3
GWW
65
3
MAC
61
3
LNC
45
-5
FE
59
3
CVS
56
2
ABT
62
2
AMAT
55
-2
ALL
60
3
EMN
73
25
EQR
36
5
LRCX
55
2
FDX
47
3
APD
44
5
MCD
39
-2
HAS
63
3
CL
54
3
LEG
47
3
IPG
33
-10
DOV
46
-10
EXPE
66
-3
GWW
65
3
MAC
61
3
LNC
45
-5
FE
59
3
CVS
56
2
ABT
62
2
AMAT
55
-2
ALL
60
3
EMN
73
25
EQR
36
5
LRCX
55
2
FDX
47
3
APD
44
5
MCD
39
-2
HAS
63
3
CL
54
3
LEG
47
3
IPG
33
-10
DOV
46
-10
Financhill
Back

Genmab AS Stock Predictions

10 Best Stocks to Own in 2025

Get your copy now FREE!
Sell
47

GMAB
Genmab AS

Last Price:
$21.34
Seasonality Move:
3.08%

7 Day Trial

ALL ACCESS PASS

$ 7

10 stocks to buy for the next leg of this rally

Get the full list here FREE

Genmab AS Stock Forecast

  • Over the next 52 weeks, Genmab AS has on average historically risen by 48.8% based on the past 15 years of stock performance.
  • Genmab AS has risen higher in 9 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Genmab AS Stock Undervalued?
    The current Genmab AS [GMAB] share price is $21.32. The Score for GMAB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • GMAB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Genmab AS Stock Go Up Next Year?

  • Over the next 52 weeks, Genmab AS has on average historically risen by 48.8% based on the past 15 years of stock performance.

Genmab AS Stock Rating

Sell
47
Genmab AS (GMAB) is a Sell

Is Genmab AS overpriced?

  • Genmab AS has risen higher in 9 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Genmab AS Stock Price History

Is GMAB stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GMAB is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
genmab.com

52-Week Data

52-Week High:
28.96
52-Week Low:
17.24

Prediction Charts

Market Cap:
13.1B
Price in USD:
21.32
Volume:
685.1K
Beta:
0.71

Technical Analysis

SMA50:
19.90
SMA100:
20.55
SMA200:
22.07
52-Wk Change:
-23.83%

Stock Predictions

  • Is Genmab AS stock public?
    Yes, Genmab AS is a publicly traded company.
  • What is the Genmab AS stock quote today?
    The Genmab AS stock price is 21.32 USD today.
  • How to buy Genmab AS stock online?
    You can buy Genmab AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-9 19.61 19.36 19.96 19.35
May-12 19.13 19.93 19.95 19.12
May-13 19.52 19.31 19.52 18.89
May-14 19.58 19.08 19.67 19.05
May-15 19.42 19.65 19.66 19.32
May-16 19.62 19.88 19.90 19.59
May-19 19.81 20.18 20.19 19.80
May-20 20.25 20.33 20.40 20.14
May-21 20.87 20.52 20.87 20.46
May-22 20.94 21.03 21.23 20.90
May-23 20.52 20.81 20.82 20.52
May-27 21.34 21.28 21.38 20.95
May-28 20.74 21.19 21.21 20.73
May-29 21.17 21.32 21.42 21.12

Genmab AS Earnings

Genmab AS Earnings Report: Per Share Genmab AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Genmab AS Forecast Revenue Growth

Genmab AS Stock Analysis: Historical quarterly revenues per share for Genmab AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $5.22 per share, an increase this year of $0.14 per share, and an increase next year of $0.30 per share.

* Genmab AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.